Fact CheckerSign in

NCT05095922CompletedPhase 4

Effect of HMP on Diabetic Microangiopaemia in T2DM

Effect of Heart-Protecting Musk Pill on Diabetic Microangiopaemia in Type 2 Diabetes Patients

Source: ClinicalTrials.gov · Last updated 9 Jul 2024

Brief summary (registry, in English)

The study mainly investigates the therapeutic effect of Heart-Protecting Musk Pill (HMP) on patients with diabetic microangiopathy. According to the indicators of diabetic nephropathy (DN), diabetic retinopathy (DR), oxidative stress and inflammatory factor in patients with diabetic microvascular disease after using HMP, the investigators aim to evaluate the effect of HMP on diabetic microangiopathy, oxidative stress and inflammation.

Status (registry)
Completed
Phase (registry)
Phase 4
Study type
Interventional
Enrollment
40 (actual)
First submitted
28 Sept 2021
Start date
28 Mar 2023
Primary completion date
30 May 2024
Lead sponsor
Affiliated Hospital of Nantong University
NCT number
NCT05095922

What you commit to

  • Study type: Interventional · Phase 4
  • Participants enrolled: 40
  • From 28 Mar 2023 to the primary completion date, 30 May 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Type 1 diabetes mellitus
  • Secondary diabetes
  • Malignant tumors
  • Active infection
  • Mental illness
  • Impaired heart function

Other

  • Acute diabetic complications
  • Macrovascular complications
  • Intellectual disability
  • Impaired liver function
  • Impaired kidney function

Who the study is looking for

  • Clinical diagnosis of Diabetes mellitus
  • Prescribed for Valsartan Capsules and Calcium Dobesilate Capsules

Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Affiliated Hospital of Nantong University
Coordinator of this site? Confirm its status
NantongChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.